Po‐Min Chen
Impact in
- Hematology top 5%
- Chronic Myeloid Leukemia Treatments
- Multiple Myeloma Research and Treatments
- Genetics top 10%
- Chronic Lymphocytic Leukemia Research
Papers in
- Hematology 23
- Multiple Myeloma Research and Treatments 7
- Hematopoietic Stem Cell Transplantation 6
- Acute Myeloid Leukemia Research 5
- Chronic Myeloid Leukemia Treatments 4
- Oncology 20
- Cancer Treatment and Pharmacology 4
- Viral-associated cancers and disorders 4
- Co-authors
- Liu H (35 shared papers)Tzeon‐Jye Chiou (26 shared papers)Wei‐Shu Wang (7 shared papers)Liang‐Tsai Hsiao (29 shared papers)Cheng‐Hwai Tzeng (20 shared papers)Jen‐Tsun Lin (6 shared papers)Tzu‐Chen Lin (4 shared papers)Jen‐Kou Lin (4 shared papers)
In The Last Decade
Po‐Min Chen
78 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 84
- Hematology 242
- Genetics 137
- Oncology 328
- Pathology and Forensic Medicine 171
- Rheumatology 92
Countries citing papers authored by Po‐Min Chen
This map shows the geographic impact of Po‐Min Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Po‐Min Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Po‐Min Chen more than expected).
Fields of papers citing papers by Po‐Min Chen
This network shows the impact of papers produced by Po‐Min Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Po‐Min Chen. The network helps show where Po‐Min Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Po‐Min Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 80 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 90 | |
| 2 | 2006 | 80 | |
| 3 | 2002 | 77 | |
| 4 | 2001 | 72 | |
| 5 | 2009 | 69 | |
| 6 | Prolonged reversible vasospasm in cyclosporin A-induced encephalopathy. | 2003 | 59 |
| 7 | 2008 | 58 | |
| 8 | 2006 | 39 | |
| 9 | 2015 | 38 | |
| 10 | 2020 | 36 | |
| 11 | 2015 | 34 | |
| 12 | 2014 | 30 | |
| 13 | 2012 | 23 | |
| 14 | 2003 | 21 | |
| 15 | Molecular lesion in chronic granulocytic leukemia is highly conserved despite ethnic and geographical variation. | 1987 | 21 |
| 16 | 2012 | 16 | |
| 17 | 2001 | 16 | |
| 18 | 2020 | 15 | |
| 19 | 2005 | 15 | |
| 20 | 2013 | 15 |
About Po‐Min Chen
Po‐Min Chen is a scholar working on Hematology, Oncology, Molecular Biology, Pathology and Forensic Medicine and Immunology, having authored 80 papers that have together received 1.2k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (8 papers), Multiple Myeloma Research and Treatments (7 papers), Hematopoietic Stem Cell Transplantation (6 papers), Acute Myeloid Leukemia Research (5 papers), Chronic Myeloid Leukemia Treatments (4 papers), Cancer Treatment and Pharmacology (4 papers), Viral-associated cancers and disorders (4 papers) and Chronic Lymphocytic Leukemia Research (4 papers). The work is most often cited by research in Hematology (242 citations), Genetics (137 citations), Oncology (328 citations), Pathology and Forensic Medicine (171 citations) and Rheumatology (92 citations). Po‐Min Chen has collaborated with scholars based in Taiwan, Japan and China. Frequent co-authors include Liu H, Tzeon‐Jye Chiou, Wei‐Shu Wang, Liang‐Tsai Hsiao, Cheng‐Hwai Tzeng, Jen‐Tsun Lin, Tzu‐Chen Lin, Jen‐Kou Lin, Huann‐Sheng Wang and Jeng‐Kae Jiang. Their work appears in journals such as Cancer Medicine, Cancer, European Journal Of Haematology, Blood and Hematological Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.